Seyed Isaac Hashemy
Overview
Explore the profile of Seyed Isaac Hashemy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
113
Citations
1340
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aliyari M, Ghoflchi S, Hashemy S, Hashemi S, Reihani A, Hosseini H
J Diabetes Metab Disord
. 2025 Jan;
24(1):52.
PMID: 39845908
Purpose: The purpose of this review study is to investigate the effect of curcumin on the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway in various diseases. Curcumin, the main...
2.
Barjasteh A, Saebi M, Mahmoudi M, Kheder R, Hashemy S, Forouzanfar F, et al.
Curr Pharm Des
. 2025 Jan;
PMID: 39757684
Cancer is a significant health challenge worldwide, causing social and economic burdens. Despite advancements in medicine, it remains a leading cause of death and is projected to increase by 2040....
3.
Mansoori S, Hashemy S, Eskandari M, Khorrami A, Homayouni M, Ghahremanloo A
Toxicol Appl Pharmacol
. 2025 Jan;
495:117224.
PMID: 39755131
Breast cancer (BC) is a leading cause of cancer-related mortality among women worldwide, with incidence rates rising globally. Urolithin B (UB), a bioactive metabolite of ellagic acid, has demonstrated promising...
4.
Dalirsani Z, Amirchaghmaghi M, Semnani M, Talebi M, Hashemy S, Shakeri M, et al.
Clin Exp Dent Res
. 2024 Dec;
10(6):e934.
PMID: 39616519
Objectives: Burning mouth syndrome (BMS) is a chronic disease in which the patient experiences a burning sensation in the oral mucosa without any pathological cause. Opiorphin is a pentapeptide that...
5.
Mohammadi F, Javid H, Afshari A, Mashkani B, Hashemy S
Mol Biol Rep
. 2024 Nov;
52(1):26.
PMID: 39612028
No abstract available.
6.
Nosrati S, Javid H, Amiri H, Jafari N, Hashemy S
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Aug;
398(2):1895-1903.
PMID: 39196393
The significant fatality rate associated with ovarian cancer underscores the urgent need for novel therapeutic interventions in this area. The focus of this study was to assess the cytotoxic impact...
7.
Aliyari M, Hashemy S, Hashemi S, Reihani A, Kesharwani P, Hosseini H, et al.
Pathol Res Pract
. 2024 Jul;
261:155479.
PMID: 39068859
Cancer is recognized as one of the leading causes of death worldwide. In recent years, advancements in early detection and expanding treatment options have contributed to a decrease in mortality...
8.
Rezaei S, Javid H, Iranpour S, Assaran Darban R, Hashemy S
Curr Med Chem
. 2024 Jul;
PMID: 38988156
Neurokinin receptors are a family of G protein-coupled receptors that were first identified in the central and peripheral nervous systems. However these receptors were later found in other types of...
9.
Einafshar E, Javid H, Amiri H, Akbari-Zadeh H, Hashemy S
Carbohydr Polym
. 2024 Jun;
340:122328.
PMID: 38857995
This article presents a novel approach to treating prostate cancer using a nanocarrier composed of folic acid (FA), β-cyclodextrin (β-CD), and magnetic graphene oxide (MGO) as a theranostic agent. The...
10.
Zarei Shandiz S, Erfani B, Hashemy S
Mol Biol Rep
. 2024 Jun;
51(1):723.
PMID: 38833199
Background: Glioblastoma multiforme, a deadly form of brain tumor, is characterized by aggressive growth and poor prognosis. Oxidative stress, a disruption in the balance between antioxidants and oxidants, is a...